STANLEY M MARKS M.D.
Prescription History 1477524924
Internal Medicine - Hematology & Oncology in Pittsburgh, PA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for STANLEY M MARKS M.D., an active Hematology & Oncology specialist practicing in Pittsburgh, PA. Our medical registry currently tracks 15 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 537 documented patient claims. Among these therapy options, the most frequently utilized medication is Letrozole, which accounts for 100 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other PA PrescribersVs. PA Avg |
|---|---|---|---|
| Letrozole | 100 | $16.22▼ below PA avg | ▲ More than typical |
About Letrozole: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women. In 2024, this provider wrote 100 Medicare prescriptions for Letrozole, about 2.1 times the volume of the typical Pennsylvania prescriber of this medication (47.6). Medicare paid an average of $16.22 per fill, versus $21.93 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 172 30-Day Fills standardized to 30-day supplies 5,081 Days of Medication total across all patients in 2024 | |||
| BrukinsaZanubrutinib | 61 | $7,547.32▼ below PA avg | ▲ More than typical |
About Brukinsa: This medication is used to treat certain cancers (mantle cell lymphoma, marginal zone lymphoma, Waldenstrom's macroglobulinemia, chronic lymphocytic leukemia, small lymphocytic lymphoma, follicular lymphoma). Show more ▾ Zanubrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. A Bruton tyrosine kinase (BTK) inhibitor for treatment of Waldenstrom macroglobulinemia. In 2024, this provider wrote 61 Medicare prescriptions for Brukinsa, about 2.3 times the volume of the typical Pennsylvania prescriber of this medication (26.1). Medicare paid an average of $7,547.32 per fill, versus $13,108.88 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 61 30-Day Fills standardized to 30-day supplies 1,801 Days of Medication total across all patients in 2024 | |||
| CalquenceAcalabrutinib Maleate | 56 | $14,088.70 | ▲ More than typical |
About Calquence: This medication is used to treat certain types of cancer (such as mantle cell lymphoma, small lymphocytic lymphoma - SLL, chronic lymphocytic leukemia - CLL). Show more ▾ Acalabrutinib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors. Inhibits Bruton’s tyrosine kinase; has antineoplastic activity. In 2024, this provider wrote 56 Medicare prescriptions for Calquence, about 2 times the volume of the typical Pennsylvania prescriber of this medication (27.7). Medicare paid an average of $14,088.70 per fill, versus $13,655.49 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 56 30-Day Fills standardized to 30-day supplies 1,680 Days of Medication total across all patients in 2024 | |||
| Exemestane | 47 | $71.34▼ below PA avg | ▲ More than typical |
About Exemestane: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Exemestane is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Exemestane decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. Exemestane is usually not used in women of childbearing age. A hormonal antineoplastic agent. In 2024, this provider wrote 47 Medicare prescriptions for Exemestane, about 1.6 times the volume of the typical Pennsylvania prescriber of this medication (30.2). Medicare paid an average of $71.34 per fill, versus $137.85 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 84.5 30-Day Fills standardized to 30-day supplies 2,535 Days of Medication total across all patients in 2024 | |||
| IbrancePalbociclib | 45 | $12,310.26▼ below PA avg | ▲ More than typical |
About Ibrance: Palbociclib is used to treat a certain type of breast cancer. Show more ▾ It works by slowing or stopping the growth of cancer cells. Has antineoplastic activity; specific inhibitor of cyclin-dependent kinases 4 & 6. In 2024, this provider wrote 45 Medicare prescriptions for Ibrance, about 1.5 times the volume of the typical Pennsylvania prescriber of this medication (29.6). Medicare paid an average of $12,310.26 per fill, versus $15,414.23 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 45 30-Day Fills standardized to 30-day supplies 1,260 Days of Medication total across all patients in 2024 | |||
| Acyclovir | 36 | $7.06▼ below PA avg | ≈ Typical |
About Acyclovir: Acyclovir is used to treat infections caused by certain types of viruses. Show more ▾ It treats cold sores around the mouth (caused by herpes simplex), shingles (caused by herpes zoster), and chickenpox. This medication is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, acyclovir is used to help reduce the number of future episodes. Acyclovir is an antiviral drug. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Acyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. In addition, in people with a weakened immune system, acyclovir can decrease the risk of the virus spreading to other parts of the body and causing serious infections. A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. In 2024, this provider wrote 36 Medicare prescriptions for Acyclovir, about 1.2 times the volume of the typical Pennsylvania prescriber of this medication (30.5). Medicare paid an average of $7.06 per fill, versus $16.58 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 36 30-Day Fills standardized to 30-day supplies 1,080 Days of Medication total across all patients in 2024 | |||
| Gabapentin | 29 | $5.45▼ below PA avg | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2024, this provider wrote 29 Medicare prescriptions for Gabapentin, about a third of the volume of the typical Pennsylvania prescriber of this medication (100.2). Medicare paid an average of $5.45 per fill, versus $14.77 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 29 30-Day Fills standardized to 30-day supplies 870 Days of Medication total across all patients in 2024 | |||
| ImbruvicaIbrutinib | 29 | $12,341.75▼ below PA avg | ≈ Typical |
About Imbruvica: This medication is used to treat certain cancers (such as chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom's macroglobulinemia). Show more ▾ Ibrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. Ibrutinib is also used to treat a certain problem that may occur after a stem cell transplant (chronic graft versus host disease). It works by weakening your body's defense system (immune system). A Btk protein inhibitor. In 2024, this provider wrote 29 Medicare prescriptions for Imbruvica, about the same volume as the typical Pennsylvania prescriber of this medication (27.9). Medicare paid an average of $12,341.75 per fill, versus $15,330.41 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 29 30-Day Fills standardized to 30-day supplies 844 Days of Medication total across all patients in 2024 | |||
| Potassium Chloride | 27 | $20.16▼ below PA avg | ▼ Less than typical |
About Potassium Chloride: This medication is a mineral supplement used to treat or prevent low amounts of potassium in the blood. Show more ▾ A normal level of potassium in the blood is important. Potassium helps your cells, kidneys, heart, muscles, and nerves work properly. Most people get enough potassium by eating a well-balanced diet. Some conditions that can lower your body's potassium level include severe prolonged diarrhea and vomiting, hormone problems such as hyperaldosteronism, or treatment with "water pills"/diuretics. A white crystal or crystalline powder used in BUFFERS; FERTILIZERS; and EXPLOSIVES. It can be used to replenish ELECTROLYTES and restore WATER-ELECTROLYTE BALANCE in treating HYPOKALEMIA. In 2024, this provider wrote 27 Medicare prescriptions for Potassium Chloride, about a third of the volume of the typical Pennsylvania prescriber of this medication (68.7). Medicare paid an average of $20.16 per fill, versus $22.50 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 45.1 30-Day Fills standardized to 30-day supplies 1,353 Days of Medication total across all patients in 2024 | |||
| Pantoprazole Sodium | 26 | $3.43▼ below PA avg | ▼ Less than typical |
About Pantoprazole Sodium: Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). Show more ▾ It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER. In 2024, this provider wrote 26 Medicare prescriptions for Pantoprazole Sodium, about a quarter of the volume of the typical Pennsylvania prescriber of this medication (100.2). Medicare paid an average of $3.43 per fill, versus $13.87 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 30 30-Day Fills standardized to 30-day supplies 900 Days of Medication total across all patients in 2024 | |||
| VenclextaVenetoclax | 25 | $7,923.08▼ below PA avg | ≈ Typical |
About Venclexta: This medication is used to treat certain types of cancer (chronic lymphocytic leukemia-CLL, small lymphocytic lymphoma-SLL, acute myeloid leukemia-AML). Show more ▾ Venetoclax is a drug that works by helping to slow or stop the growth of cancer cells. A BCL-2 inhibitor with antineoplastic activity that is used in the treatment of CHRONIC LYMPHOCYTIC LEUKEMIA associated with chromosome 17p deletion. In 2024, this provider wrote 25 Medicare prescriptions for Venclexta, about the same volume as the typical Pennsylvania prescriber of this medication (26.6). Medicare paid an average of $7,923.08 per fill, versus $8,667.69 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 25 30-Day Fills standardized to 30-day supplies 710 Days of Medication total across all patients in 2024 | |||
| Tamoxifen Citrate | 22 | $32.43 | ▼ Less than typical |
About Tamoxifen Citrate: Tamoxifen is used to treat breast cancer. Show more ▾ It is also used to reduce the chances of breast cancer in high-risk patients. This medication can block the growth of breast cancer. It works by interfering with the effects of estrogen in the breast tissue. One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. In 2024, this provider wrote 22 Medicare prescriptions for Tamoxifen Citrate, about 68% of the volume of the typical Pennsylvania prescriber of this medication (32.2). Medicare paid an average of $32.43 per fill, versus $28.64 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 51 30-Day Fills standardized to 30-day supplies 1,494 Days of Medication total across all patients in 2024 | |||
| ValacyclovirValacyclovir Hcl | 12 | $15.67▼ below PA avg | ▼ Less than typical |
About Valacyclovir: Valacyclovir is used to treat infections caused by certain types of viruses. Show more ▾ In children, it is used to treat cold sores around the mouth (caused by herpes simplex) and chickenpox (caused by varicella zoster). In adults, it is used to treat shingles (caused by herpes zoster) and cold sores around the mouth. Valacyclovir is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, this medication is used to reduce the number of future episodes. Valacyclovir is an antiviral drug. It stops the growth of certain viruses. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Valacyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. A prodrug of acyclovir that is used in the treatment of HERPES ZOSTER and HERPES SIMPLEX VIRUS INFECTION of the skin and mucous membranes, including GENITAL HERPES. In 2024, this provider wrote 12 Medicare prescriptions for Valacyclovir, about half the volume of the typical Pennsylvania prescriber of this medication (21.9). Medicare paid an average of $15.67 per fill, versus $29.74 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 16 30-Day Fills standardized to 30-day supplies 451 Days of Medication total across all patients in 2024 | |||
| Escitalopram Oxalate | 11 | $18.94 | ▼ Less than typical |
About Escitalopram Oxalate: This medication is used to treat certain mental/mood disorders (such as depression, anxiety). Show more ▾ Escitalopram belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRIs). It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. S-enantiomer of CITALOPRAM. Belongs to a class of drugs known as SELECTIVE SEROTONIN REUPTAKE INHIBITORS, used to treat depression and generalized anxiety disorder. In 2024, this provider wrote 11 Medicare prescriptions for Escitalopram Oxalate, about 16% of the volume of the typical Pennsylvania prescriber of this medication (66.7). Medicare paid an average of $18.94 per fill, versus $12.00 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 19 30-Day Fills standardized to 30-day supplies 570 Days of Medication total across all patients in 2024 | |||
| PromactaEltrombopag Olamine | 11 | $13,030.09▼ below PA avg | ▼ Less than typical |
About Promacta: This medication is used to treat low platelet levels in people who have a certain blood disorder called chronic immune (idiopathic) thrombocytopenia purpura (ITP) or who have chronic hepatitis C. Show more ▾ It may also be used to treat people with a certain blood disorder (aplastic anemia). Platelets are a type of blood cell needed to form blood clots and prevent bleeding. Eltrombopag decreases your risk of bleeding by increasing the number of platelets. Eltrombopag acts like a certain natural substance (thrombopoietin) that causes the body to produce platelets. An oral, nonpeptide thrombopoietin receptor agonist. In 2024, this provider wrote 11 Medicare prescriptions for Promacta, about 68% of the volume of the typical Pennsylvania prescriber of this medication (16.2). Medicare paid an average of $13,030.09 per fill, versus $14,903.60 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for STANLEY M MARKS M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hematology & Oncology prescribing approach at this Pittsburgh, PA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among PA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
